CAPTRUST Financial Advisors
NKTR icon

CAPTRUST Financial Advisors’s Nektar Therapeutics NKTR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,143
Closed -$21.9K – 2571
2025
Q1 		$21.9K Buy
2,143
+1,343
+168% +$17.5K ﹤0.01% 2317
2024
Q4 		$11.2K Sell
800
-50
-6% -$882 ﹤0.01% 2278
2024
Q3 		$16.6K Buy
850
+50
+6% +$953 ﹤0.01% 2263
2024
Q2 		$14.9K Hold
800
– – ﹤0.01% 2177
2024
Q1 		$11.2K Sell
800
-2
-0.2% -$21 ﹤0.01% 2121
2023
Q4 		$6.79K Sell
802
-409
-34% -$3.1K ﹤0.01% 2641
2023
Q3 		$10.8K Buy
1,211
+239
+25% +$2.3K ﹤0.01% 2537
2023
Q2 		$8.39K Sell
972
-307
-24% -$3.27K ﹤0.01% 2487
2023
Q1 		$13.5K Buy
+1,279
New +$38.7K ﹤0.01% 2263
2022
Q4 		– Sell
-1,537
Closed -$74K – 2142
2022
Q3 		$74K Buy
1,537
+1,318
+602% +$78.4K ﹤0.01% 1962
2022
Q2 		$13K Buy
219
+24
+12% +$1.51K ﹤0.01% 3609
2022
Q1 		$16K Buy
195
+66
+51% +$9.77K ﹤0.01% 3532
2021
Q4 		$26K Buy
129
+18
+16% +$3.9K ﹤0.01% 3119
2021
Q3 		$30K Buy
111
+3
+3% +$721 ﹤0.01% 2903
2021
Q2 		$28K Hold
108
– – ﹤0.01% 2888
2021
Q1 		$32K Buy
108
+85
+370% +$26.5K ﹤0.01% 2702
2020
Q4 		$6K Buy
23
+4
+21% +$1.03K ﹤0.01% 2780
2020
Q3 		$5K Buy
+19
New +$5.98K ﹤0.01% 2534
2019
Q3 		– Sell
-4
Closed -$2K – 1993
2019
Q2 		$2K Buy
+4
New +$2.01K ﹤0.01% 1811

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAPTRUST Financial Advisors's NKTR Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 2,143 shares — an estimated $21.9K sold.

CAPTRUST Financial Advisors first reported a position in NKTR in Q2 2019 and held it in 19 quarters. The position peaked at $74K in Q3 2022. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,143 Nektar Therapeutics shares in Q2 2025, an estimated $21.9K.
  • CAPTRUST Financial Advisors first reported a position in Nektar Therapeutics in Q2 2019 and held it in 19 quarters.
  • CAPTRUST Financial Advisors's Nektar Therapeutics position peaked at $74K in Q3 2022.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.